Frozen PRP treatment for maxillary sinus floor elevation.

Safety evaluation of frozen PRP treatment for maxillary sinus floor elevation. - Frozen PRP treatment for maxillary sinus floor elevation.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTc030220692

Enrollment

Registered

2023-03-10

Start date

2024-03-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrophic maxillary alveolar bone

Interventions

administration of cell processing products.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Have missing tooth in the maxillary posterior region. 2) Require dental implant treatment at missing tooth site. 3) Have good systemic condition. 4) Number of platelet is over 1x10E9/liter. 5) 18 years and older. 6) Other,the investigator believes makes him/her suitable for participation in this clinical study.

Exclusion criteria

Exclusion criteria: 1) Have a history of Complicate malignant tumor. 2) Have an abnormal gingival proliferation or having a history of abnormal gingival proliferation. 3) Suspected of oral malignant tumor or precancerous lesion. 4) Under 18 years of old. 5) Have anti-coagulant or anti-platelet medications, or have a bleeding disorders. 6) Pregnancy, breastfeeding, or possibility of pregnancy. 7) Other,the investigator believes makes him/her unsuitable for participation in the clinical study.

Design outcomes

Primary

Measure	Time frame
Safety	—

Secondary

Measure	Time frame
Efficacy	—

Countries

Japan

Contacts

Public ContactMika Iguchi

Juntendo university

m.iguchi.vm@juntendo.ac.jp+81-3-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026